Immunomodulator OM 163-induced reversal of tumor-mediated immunosuppression and downregulation of TGF-β1 in vivo

article
Although PROb colonic tumor cells are immunosuppressive, the immunomodulator OM 163 induced the disappearance of macroscopic peritoneal nodules in 50% of rats bearing a peritoneal carcinomatosis (p.c.) induced by PROb cells. When the p.o. developed, the number of T lymphocytes was low and the expression of interferon (IFN)-γ mRNA in tumor nodules decreased very rapidly. The TGF-β1 secreted by PROb cells could be responsible for the immunosuppression, because the PROb cell supernatant inhibited IFN-γ production and T lymphocyte proliferation. When the rats were treated with OM 163, an infiltration of T lymphocytes was observed in tumor nodules, as well as a high expression of the IFN-γ mRNA. The antitumor efficiency of the immunomodulator OM 163 could be explained in part by a direct effect of OM 163 on T lymphocytes, because in vitro it stimulated the proliferation and the secretion of IFN-γ of T lymphocytes. OM 163 could also act at the TGF- β1 level. Although OM 163 alone or in combination with IFN-γ did not modify the TGF-β1 secretion by PROb cells in vitro, the expression of the TGF-β1 mRNA and the TGF-β1 protein content was decreased in vivo in treated tumor nodules.
TNO Identifier
233409
ISSN
0022-3565
Source
Journal of Pharmacology and Experimental Therapeutics, 278(2), pp. 926-933.
Pages
926-933
Files
To receive the publication files, please send an e-mail request to TNO Repository.